Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Lightbody

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Immunological Communications|January 1, 1978
Factors affecting the stimulating capacity of mitogen-transformed, glutaraldehyde-treated mouse spleen cells in the mixed lymphocyte reactionJ J Lightbody, Y C Kong
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1976
Mitogen-stimulated glutaraldehyde-fixed spleen cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in cell-mediated lympholysisJ J Lightbody, Y M Kong
Molecular Biology of the Cell|September 1, 1996
CDC37 is required for p60v-src activity in yeastB Dey, J J Lightbody, F Boschelli
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1979
The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activationJ Uberti, J J Lightbody, R M Johnson
Cancer Research|January 1, 1975
Decreased lymphocyte adenosine deaminase activity in acute lymphocytic leukemia children and their parentsJ Zimmer, A S Khalifa, J J Lightbody
Journal of Cell Science|June 1, 1993
The lethality of p60v-src in Saccharomyces cerevisiae and the activation of p34CDC28 kinase are dependent on the integrity of the SH2 domainF Boschelli, S M Uptain, J J Lightbody
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1976
Isolation of a human lymphocyte mitogen from wheat germ with N-acetyl-D-glucosamine specificityJ M Brown, M A Leon, J J Lightbody
In Vitro|May 1, 1978
Suppression of lymphocyte proliferation by a nonspecific factor produced by the Burkitt lymphoma-derived lymphoblast cell lineJ J Lightbody, W D Peterson, M D Poulik
Cancer Research|June 1, 1976
Decreased lymphocyte adenosine deaminase activity in tumor patientsJ Uberti, R M Johnson, R Talley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell lineJ Uberti, W D Peterson, J J Lightbody, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Immunological Communications|January 1, 1978
Factors affecting the stimulating capacity of mitogen-transformed, glutaraldehyde-treated mouse spleen cells in the mixed lymphocyte reactionJ J Lightbody, Y C Kong
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1976
Mitogen-stimulated glutaraldehyde-fixed spleen cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in cell-mediated lympholysisJ J Lightbody, Y M Kong
Molecular Biology of the Cell|September 1, 1996
CDC37 is required for p60v-src activity in yeastB Dey, J J Lightbody, F Boschelli
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1979
The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activationJ Uberti, J J Lightbody, R M Johnson
Cancer Research|January 1, 1975
Decreased lymphocyte adenosine deaminase activity in acute lymphocytic leukemia children and their parentsJ Zimmer, A S Khalifa, J J Lightbody
Journal of Cell Science|June 1, 1993
The lethality of p60v-src in Saccharomyces cerevisiae and the activation of p34CDC28 kinase are dependent on the integrity of the SH2 domainF Boschelli, S M Uptain, J J Lightbody
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1976
Isolation of a human lymphocyte mitogen from wheat germ with N-acetyl-D-glucosamine specificityJ M Brown, M A Leon, J J Lightbody
In Vitro|May 1, 1978
Suppression of lymphocyte proliferation by a nonspecific factor produced by the Burkitt lymphoma-derived lymphoblast cell lineJ J Lightbody, W D Peterson, M D Poulik
Cancer Research|June 1, 1976
Decreased lymphocyte adenosine deaminase activity in tumor patientsJ Uberti, R M Johnson, R Talley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell lineJ Uberti, W D Peterson, J J Lightbody, et al.
Pageof 2